McNeill Jonathan
Dyne Therapeutics, Inc. · Chief Business Officer
McNeill Jonathan is listed in filings as Chief Business Officer at Dyne Therapeutics, Inc.. This profile follows SEC Form 4 activity through Aug 20, 2024, including sale activity. Recent filings connect the profile to Dyne Therapeutics, Inc. (DYN). The current snapshot covers public activity from Jun 11, 2024 to Aug 20, 2024. Reported amounts are shown as $57.1K to $108.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $14k305 shares | SellAug 19, 2024 | $46.00 | $18.16 | |
| $108k2.4k shares | SellAug 19, 2024 | $45.01 | $18.16 |